等待开盘 07-31 09:30:00 美东时间
0.000
0.00%
Clearmind Medicine Inc. announced a historic milestone as the first participant was dosed with its proprietary CMND-100, an oral psychedelic-derived drug candidate, in a Phase I/IIa clinical trial for Alcohol Use Disorder (AUD). Conducted at leading institutions including Yale and Johns Hopkins, the trial aims to evaluate the safety, tolerability, and efficacy of CMND-100 in reducing alcohol cravings and consumption. This marks the first time the...
06-30 13:16
Clarim Acquisition Corp. (NASDAQ:CLRM – Get Rating) was the target of a signifi...
2022-09-01 01:22
油气服务巨头贝克休斯的董事长兼CEO洛伦佐·西蒙内利(Lorenzo Simonelli )周一表示,他预计到2030年,全球液化天然气(LNG)产能需要增加到...
2021-09-27 13:01
美国私人监狱运营商Geo Group的股价周三一度暴涨73%,至11美元,收盘上涨38.36%。报8.80美元。尽管该公司正在一个对私人监狱运营商日益不利的世界...
2021-06-10 11:26
根据区块链分析公司Chainalysis的一份报告,美国人2020年投资比特币的实现收益据估计达41亿美元,在全球排名第一。 Chainalysis研究总监K...
2021-06-10 10:47